As a previous study has shown that folate–miR-34a is selectively targeted to breast and lung cancers overexpressing FOLR1 [21], we first confirmed the functionality of our folate–miR-34a using the MDA-MB-231 breast cancer cells as the experimental control. This evidence concerns the gene FOLR1 and lung carcinoma.